within Pharmacolibrary.Drugs.ATC.G;

model G01AA05_1
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.8,
    Cl             = 7.5 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 1000 / 1000000,
    adminCount     = 1,
    Vd             = 0.0005,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0011666666666666668,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Chloramphenicol is a broad-spectrum antibiotic that was historically used to treat a wide range of bacterial infections, including typhoid fever, meningitis, and eye infections. Due to serious adverse effects such as aplastic anemia and bone marrow suppression, its use is now restricted or avoided in many countries, reserved mainly for severe infections when alternative antibiotics are ineffective or contraindicated.</p><h4>Pharmacokinetics</h4><p>Parameters estimated for oral administration in healthy adults.</p><h4>References</h4><ol><li><p>KuKanich, B, &amp; KuKanich, K (2015). Chloramphenicol significantly affects the pharmacokinetics of oral methadone in Greyhound dogs. <i>Veterinary anaesthesia and analgesia</i> 42(6) 597–607. DOI:<a href=&quot;https://doi.org/10.1111/vaa.12257&quot;>10.1111/vaa.12257</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/25733012/&quot;>https://pubmed.ncbi.nlm.nih.gov/25733012</a></p></li><li><p>McElligott, EM, et al., &amp; Cox, SK (2017). Pharmacokinetics of chloramphenicol base after oral administration in adult horses. <i>Journal of the American Veterinary Medical Association</i> 251(1) 90–94. DOI:<a href=&quot;https://doi.org/10.2460/javma.251.1.90&quot;>10.2460/javma.251.1.90</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/28621597/&quot;>https://pubmed.ncbi.nlm.nih.gov/28621597</a></p></li><li><p>Crump, JA, et al., &amp; Parry, CM (2015). Epidemiology, Clinical Presentation, Laboratory Diagnosis, Antimicrobial Resistance, and Antimicrobial Management of Invasive Salmonella Infections. <i>Clinical microbiology reviews</i> 28(4) 901–937. DOI:<a href=&quot;https://doi.org/10.1128/CMR.00002-15&quot;>10.1128/CMR.00002-15</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/26180063/&quot;>https://pubmed.ncbi.nlm.nih.gov/26180063</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end G01AA05_1;
